Breaking News Instant updates and real-time market news.

GE

General Electric

$28.89

0.12 (0.42%)

, VIPS

Vipshop

$14.33

0.02 (0.14%)

07:30
10/17/16
10/17
07:30
10/17/16
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Friday in GE (GE), Vipshop (VIPS), 21st Century Fox (FOXA), Dominos (DPZ), MGIC (MTG), and Halozyme Therapeutics (HALO).

GE

General Electric

$28.89

0.12 (0.42%)

VIPS

Vipshop

$14.33

0.02 (0.14%)

FOXA

21st Century Fox

$24.73

0.17 (0.69%)

DPZ

Domino's Pizza

$151.12

0.81 (0.54%)

MTG

MGIC Investment

$7.99

0.03 (0.38%)

HALO

Halozyme

$10.06

-0.45 (-4.28%)

  • 18

    Oct

  • 18

    Oct

  • 21

    Oct

  • 07

    Nov

  • 14

    Nov

  • 17

    Nov

  • 29

    Nov

GE General Electric
$28.89

0.12 (0.42%)

10/14/16
UBSW
10/14/16
NO CHANGE
Target $34
UBSW
Buy
General Electric price target lowered to $34 from $37 at UBS
UBS analyst Shannon O'Callaghan lowered his price target on General Electric to $34 from $37 ahead of its Q3 results. The analyst lowered his Q3 estimates to reflect a more cautious view on growth amid continued soft industrial trends. O'Callaghan believes the quarter will be ok but that Q4 will be better. O'Callaghan maintained his Buy rating on General Electric shares.
09/07/16
BERN
09/07/16
NO CHANGE
BERN
General Electric deal a long-term positive, says Bernstein
After GE acquired two European 3D printer companies, Bernstein analyst Steven Winoker says that the transaction will enable GE to more easily integrate 3D printing into its businesses. The analyst says that the productivity benefits that GE can realize from the deal are "self-evident," and he predicts that the deal will save GE money over the long-term. Winoker keeps a Market Perform rating on the stock.
07/22/16
07/22/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. General Electric (GE) initiated with a Sell at Standpoint Research. 2. Williams (WMB) and Williams Partners (WPZ) resumed with a Neutral at Citi. 3. Nevro (NVRO) initiated with an Overweight at Piper Jaffray. 4. Universal Electronics (UEIC) initiated with a Buy at Sidoti. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/22/16
STPT
07/22/16
INITIATION
Target $26
STPT
Sell
General Electric initiated with a Sell at Standpoint Research
Target $26.
VIPS Vipshop
$14.33

0.02 (0.14%)

08/17/16
DBAB
08/17/16
DOWNGRADE
DBAB
Hold
Vipshop downgraded to Hold from Buy at Deutsche Bank
08/31/16
JPMS
08/31/16
INITIATION
Target $16
JPMS
Neutral
Vipshop assumed with a Neutral at JPMorgan
JPMorgan analyst Alex Yao assumed coverage of Vipshop with a Neutral rating and $16 price target. The rating is unchanged and the price target is raised from $16.
08/17/16
DBAB
08/17/16
DOWNGRADE
Target $16.9
DBAB
Hold
Vipshop downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Alan Hellawell downgraded Vipshop to Hold saying the shares are nearing fair value following the company's Q2 results. The analyst raised his price target for the stock to $16.90 from $16.60.
08/17/16
BMUR
08/17/16
NO CHANGE
Target $21
BMUR
Buy
Vipshop price target raised to $21 from $15 at Brean Capital
Brean Capital analyst Fawne Jiang raised her price target on Vipshop to $21 from $15 following strong Q2 results which showed an acceleration of revenue growth, new user growth, and stable margins. Jiang reiterated her Buy rating on Vipshop shares.
FOXA 21st Century Fox
$24.73

0.17 (0.69%)

09/26/16
UBSW
09/26/16
NO CHANGE
Target $92
UBSW
Neutral
Consumer satisfaction with competitors has caught up to Netflix, says UBS
UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.
09/16/16
BERN
09/16/16
DOWNGRADE
BERN
Market Perform
21st Century Fox downgraded to Market Perform from Outperform at Bernstein
As noted earlier, Bernstein downgraded 21st Century Fox to Market Perform from Outperform. Analyst Jason Park based the downgrade on a reduction in his estimates for the company's Star India business. However, he thinks the company faces many other risks, including lower domestic affiliate fees, lower overseas advertising revenue, and higher cable network expenses. Additionally, he thinks that investors will remain skeptical about the stock even if the company beats his estimates. Target $26.
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/14/16
RBCM
10/14/16
NO CHANGE
RBCM
21st Century Fox setup into results positive, says RBC Capital
RBC Capital analyst Steven Cahall thinks that 21st Century Fox's stock will react positively to its Q1 results despite the weak performance of its films and "mild weakness" in broadcast ratings. If no other problems emerge, the stock can rise, the analyst believes. He thinks that the stock's valuation is attractive
DPZ Domino's Pizza
$151.12

0.81 (0.54%)

10/14/16
10/14/16
UPGRADE
Target $175

Buy
Domino's Pizza upgraded two notches on growth opportunity at BofA/Merrill
As previously reported, BofA/Merrill upgraded Domino's Pizza two notches to Buy from Underperform and raised its price target to $175 from $120. Analyst Gregory Francfort believes Domino's has further growth ahead and will take share in the fragmented $34B US pizza category. The analyst expects 7.3% domestic system sales growth over the next six years and said shares discount 6.7% growth. He expects Domino's sales growth to continue driven by modest growth in the quick service pizza category, general market share gains by large chains due to digital ordering advantages, remodeling and relocation upgrades, digital customer data lead following its loyalty rollout, and impressive management.
07/05/16
LBOW
07/05/16
NO CHANGE
Target $145
LBOW
Buy
Domino's Pizza Q2 comps above consensus, says Longbow
Longbow analyst Alton Stump's checks indicate Domino's Pizza's domestic franchised same-store-sales were up in a 7%-7.5% range in Q2, in line with his 7.3% franchised comp growth estimate but ahead of consensus of 6.2%. Stump reiterates his Buy rating and $145 price target on Domino's shares.
10/14/16
BOFA
10/14/16
UPGRADE
BOFA
Buy
Domino's Pizza upgraded to Buy from Underperform at BofA/Merrill
10/14/16
10/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConAgra (CAG) upgraded to Outperform from Sector Perform at RBC Capital with analyst David Palmer citing valuation. 2. Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray after the firm's semi-annual proprietary "Taking Stock With Teens" survey. 3. Domino's Pizza (DPZ) upgraded to Buy from Underperform at BofA/Merrill with analyst Gregory Francfort saying he believes Domino's has further growth ahead and will take share in the fragmented $34B U.S. pizza category. 4. TSMC (TSM) upgraded to Sector Weight from Underweight at Pacific Crest with analyst Michael McConnell citing a more favorable margin outlook and share gains at the 10 nm node. 5. Level 3 (LVLT) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying expectations have been lowered along with the share price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MTG MGIC Investment
$7.99

0.03 (0.38%)

07/20/16
07/20/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Papa John's (PZZA) upgraded to Overweight from Sector Weight at KeyBanc with analyst Chris O'Cull saying the "civil and political disruptions" that have been hurting restaurant dining could be helping pizza operators that deliver to consumers. 2. Scripps Networks (SNI) upgraded to Buy from Hold at Stifel with the firms saying it expects the company to benefit from stronger than expected domestic ad trends, as well as affiliate fee growth that it believes will surpass the average of its peers. 3. MGIC Investment (MTG) upgraded to Buy from Neutral at Compass Point with the firm saying it revised estimates higher to incorporate lower default-to-claim assumptions and a gradual decline in the reserve per late stage default, which translates to a lower incurred loss estimates. 4. LATAM Airlines (LFL) upgraded to Buy from Hold at Deutsche Bank with analyst Michael Linenberg citing improving economies in Latin America and significant capacity cuts among airliners. 5. Brookfield Renewable (BEP) upgraded to Buy from Neutral at Guggenheim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/16
07/20/16
UPGRADE
Target $9

Buy
MGIC Investment upgraded to Buy at Compass Point
As previously reported, Compass Point upgraded MGIC Investment to Buy from Neutral and raised its price target to $9 from $8.50. The analyst revised estimates higher to incorporate lower default-to-claim assumptions and a gradual decline in the reserve per late stage default, which translates to a lower incurred loss estimates.
07/20/16
COMP
07/20/16
UPGRADE
COMP
Buy
MGIC Investment upgraded to Buy from Neutral at Compass Point
10/17/16
BOFA
10/17/16
INITIATION
Target $10
BOFA
Buy
MGIC Investment initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Mihir Bhatia initiated MGIC Investment with a Buy and a $10 price target.
HALO Halozyme
$10.06

-0.45 (-4.28%)

09/16/16
PIPR
09/16/16
NO CHANGE
Target $18
PIPR
Overweight
Halozyme price target raised to $18 from $15 at Piper Jaffray
Piper Jaffray analyst Charles Duncan raised his price target for Halozyme Therapeutics to $18 after hosting investor meetings with management. The analyst now has increased conviction in the long-term value of the company's ENHANZE products. He reiterates an Overweight rating on the shares.
02/01/16
02/01/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Acadia (ACHC) initiated with an Overweight at KeyBanc... Altisource Residential (RESI) initiated with a Neutral at Nomura... Colony Starwood Homes (SFR) initiated with a Buy at Nomura... EyeGate (EYEG) initiated with a Buy at Rodman & Renshaw... Fortinet (FTNT) initiated with an Outperform at Northland... Halozyme (HALO) initiated with a Buy at Canaccord... Lendingtree (TREE) initiated with an Outperform at Northland... Lindblad Expeditions (LIND) initiated with an Outperform at Credit Suisse... Summit Therapeutics (SMMT) initiated with a Buy at Canaccord... VolitionRx (VNRX) initiated with a Buy at Rodman & Renshaw.
02/01/16
ADAM
02/01/16
INITIATION
Target $10
ADAM
Buy
Halozyme initiated with a Buy at Canaccord
Target $10.
01/20/16
UBSW
01/20/16
NO CHANGE
Target $22
UBSW
Buy
Halozyme price target lowered to $22 from $28 at UBS
UBS lowered its price target on Halozyme to $22 from $28 due to the recent market weakness in the biotech sector. The firm said the company's recent data on its drug was not well received, but still suggests a potential new standard of care in pancreatic cancer. UBS maintained its Buy rating on Halozyme shares.

TODAY'S FREE FLY STORIES

KBR

KBR

$14.05

-1.43 (-9.24%)

18:47
04/28/17
04/28
18:47
04/28/17
18:47
Hot Stocks
KBR issues statement on SFO investigation »

KBR made the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

SMMT

Summit Therapeutics

$11.00

-0.4 (-3.51%)

18:32
04/28/17
04/28
18:32
04/28/17
18:32
Hot Stocks
Summit Therapeutics publishes results from CoDIFy trial online »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKPYY

Takeda Pharmaceutical Co. Ltd.

$24.83

0.85 (3.54%)

18:14
04/28/17
04/28
18:14
04/28/17
18:14
Hot Stocks
Takeda says FDA grants accelerated approval of ALUNBRIG »

Takeda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNBC

First NBC Bank

$2.65

-0.2 (-7.02%)

18:07
04/28/17
04/28
18:07
04/28/17
18:07
Hot Stocks
FDIC named receiver of First NBC Bank »

First NBC Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGBK

Stonegate Bank

$45.90

-0.52 (-1.12%)

17:47
04/28/17
04/28
17:47
04/28/17
17:47
Earnings
Stonegate Bank reports Q1 non-GAAP EPS 56c, consensus 57c »

Reports Q1 NII $25.89M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PROV

Provident Financial

$19.23

-0.03 (-0.16%)

17:45
04/28/17
04/28
17:45
04/28/17
17:45
Hot Stocks
Provident Financial announces extension of stock repurchase plan »

Provident Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

YGE

Yingli Green Energy

$2.66

-0.03 (-1.12%)

17:40
04/28/17
04/28
17:40
04/28/17
17:40
Hot Stocks
Yingli Green Energy files extension for 2016 Form 20-F filing »

Yingli Green Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPC

Edgewell Personal Care

$71.49

-0.14 (-0.20%)

17:40
04/28/17
04/28
17:40
04/28/17
17:40
Hot Stocks
Breaking Hot Stocks news story on Edgewell Personal Care »

Gabelli raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

ORC

Orchid Island Capital

$10.60

-0.33 (-3.02%)

17:35
04/28/17
04/28
17:35
04/28/17
17:35
Syndicate
Breaking Syndicate news story on Orchid Island Capital »

Orchid Island Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    Jun

AEP

American Electric

$67.83

-0.27 (-0.40%)

17:35
04/28/17
04/28
17:35
04/28/17
17:35
Hot Stocks
AEP Generation Resources seeks bids for supply of coal »

AEP Generation Resources,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORC

Orchid Island Capital

$10.60

-0.33 (-3.02%)

17:34
04/28/17
04/28
17:34
04/28/17
17:34
Syndicate
Breaking Syndicate news story on Orchid Island Capital »

Orchid Island Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    Jun

HBHC

Hancock Holding

$46.70

-0.5 (-1.06%)

, FNBC

First NBC Bank

$2.65

-0.2 (-7.02%)

17:34
04/28/17
04/28
17:34
04/28/17
17:34
Hot Stocks
Whitney to acquire branches, assets, liabilities of First NBC from FDIC »

Hancock Holding Company…

HBHC

Hancock Holding

$46.70

-0.5 (-1.06%)

FNBC

First NBC Bank

$2.65

-0.2 (-7.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TSLA

Tesla

$314.07

5.44 (1.76%)

17:31
04/28/17
04/28
17:31
04/28/17
17:31
Periodicals
Tesla aims to hire engineers from Mexico to work at CA plant, Reuters says »

Tesla is aiming to hire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 30

    May

LMT

Lockheed Martin

$269.45

-1.69 (-0.62%)

17:22
04/28/17
04/28
17:22
04/28/17
17:22
Hot Stocks
Lockheed Martin awarded $332.1M government contract »

Lockheed Martin, Orlando,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BA

Boeing

$184.83

1.61 (0.88%)

17:21
04/28/17
04/28
17:21
04/28/17
17:21
Hot Stocks
Boeing awarded $541M government contract modification »

The Boeing Co., Ridley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

WBA

Walgreens Boots Alliance

$86.54

0.65 (0.76%)

, RAD

Rite Aid

$4.00

0.05 (1.27%)

17:20
04/28/17
04/28
17:20
04/28/17
17:20
Periodicals
Walgreens to push regulators over decision on Rite Aid deal, NY Post says »

Walgreens (WBA) will…

WBA

Walgreens Boots Alliance

$86.54

0.65 (0.76%)

RAD

Rite Aid

$4.00

0.05 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$28.99

-0.09 (-0.31%)

17:20
04/28/17
04/28
17:20
04/28/17
17:20
Hot Stocks
General Electric awarded $670.7M government contract »

General Electric, Lynn,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 31

    May

  • 22

    Jun

SIX

Six Flags

$62.61

-0.26 (-0.41%)

17:19
04/28/17
04/28
17:19
04/28/17
17:19
Hot Stocks
Six Flags in agreement to repurchase 5M shares from HP Partners »

Six Flags Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 17

    May

  • 18

    May

LMT

Lockheed Martin

$269.45

-1.69 (-0.62%)

17:18
04/28/17
04/28
17:18
04/28/17
17:18
Hot Stocks
Lockheed Martin awarded $1.38B government contract »

Lockheed Martin Corp.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SBBP

Strongbridge Biopharma

$4.50

0.05 (1.12%)

17:16
04/28/17
04/28
17:16
04/28/17
17:16
Syndicate
Breaking Syndicate news story on Strongbridge Biopharma »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

CYH

Community Health

$8.61

0.18 (2.14%)

17:12
04/28/17
04/28
17:12
04/28/17
17:12
Hot Stocks
Community Health completes divestiture of Anniston, Alabama hospital »

Community Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 06

    Jun

MRUS

Merus

$22.20

-0.14 (-0.63%)

17:07
04/28/17
04/28
17:07
04/28/17
17:07
Earnings
Merus reports Q4 EPS (EUR1.91) vs. (EUR0.77) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

AEZS

Aeterna Zentaris

$3.35

0.3 (9.84%)

17:01
04/28/17
04/28
17:01
04/28/17
17:01
Hot Stocks
Aeterna Zentaris to announces top-line Zoptrex phase 3 results on Monday »

Aeterna Zentaris will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

ANY

Sphere 3D

$0.19

-0.006 (-3.13%)

17:00
04/28/17
04/28
17:00
04/28/17
17:00
Syndicate
Breaking Syndicate news story on Sphere 3D »

Sphere 3D files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

MRUS

Merus

$22.20

-0.14 (-0.63%)

16:56
04/28/17
04/28
16:56
04/28/17
16:56
Hot Stocks
Merus provides anticipated 2017 pipeline milestones »

Merus provided 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.